FIELD: chemical-pharmaceutical industry.
SUBSTANCE: invention relates to a pharmaceutical tablet comprising a medicinal agent taken in the therapeutically and/or prophylactically effective amount. Tablet has a core disintegrated in mouth cavity and an envelope made of an adjusting excipient wherein envelope comprises hellanic gum. Practically all medicinal agent is comprised in the core and doesn't mixed with hellanic gum and wherein a medicinal agent represents compound of the formula (I)
wherein X means oxygen (O) or sulfur (S) atom, or its pharmaceutically acceptable salt.
EFFECT: improved and valuable pharmaceutical properties of formulation.
7 cl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL TABLET | 2003 |
|
RU2273473C2 |
MEDICINAL FORMS AND METHOD OF TREATMENT OF MALE ERECTILE FUNCTION | 1998 |
|
RU2204413C2 |
SOLID PHARMACEUTICAL COMPOSITION FOR IMPROVEMENT OF MAIL ERECTILITY FUNCTION | 2005 |
|
RU2283650C1 |
DELAYED RELEASE PILL CONTAINING REBOXETIN | 2003 |
|
RU2292873C2 |
ORAL DISINTEGRATING DOSAGE FORM OF AVANAFIL AND RELATED METHODS FOR PREPARING AND USING IT | 2015 |
|
RU2740903C2 |
MEDICINE DELIVERY REGULATED SYSTEM CONTAINED IN STOMACH | 2002 |
|
RU2325152C2 |
PHARMACEUTICAL COMPOSITIONS | 2004 |
|
RU2364400C2 |
METERIAL IN FORM OF PARTICLES FOR CONTROLLED RELEASE OF ACTIVE INGREDIENTS | 2010 |
|
RU2530655C2 |
FILM-COVERED TABLET OF IMPROVED SAFETY FOR UPPER DEPARTMENTS OF GASTROINTESTINAL TRACT | 1998 |
|
RU2193880C2 |
SOLID COMPOSITION FOR DELIVERY | 2018 |
|
RU2812928C2 |
Authors
Dates
2006-10-20—Published
2003-02-06—Filed